These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2533182)

  • 1. Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days.
    Hanhijärvi H; Elomaa I; Karlsson M; Lauren L
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):602-6. PubMed ID: 2533182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pharmacokinetics of clodronate after single and repeated doses.
    Ylitalo P; Holli K; Mönkkönen J; Elo HA; Juhakoski A; Liukko-Sipi S; Ylitalo R
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):294-300. PubMed ID: 10395121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of clodronate in renal failure.
    Saha H; Castren-Kortekangas P; Ojanen S; Juhakoski A; Tuominen J; Tokola O; Pasternack A
    J Bone Miner Res; 1994 Dec; 9(12):1953-8. PubMed ID: 7872061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three intravenous regimens of clodronate in Paget disease of bone.
    Khan SA; McCloskey EV; Eyres KS; Nakatsuka K; Sirtori P; Orgee J; Coombes G; Kanis JA
    J Bone Miner Res; 1996 Feb; 11(2):178-82. PubMed ID: 8822341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL; Barriere SL; Kitt MM; Goldberg MR
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.
    Supko JG; Eder JP; Ryan DP; Seiden MV; Lynch TJ; Amrein PC; Kufe DW; Clark JW
    Clin Cancer Res; 2003 Nov; 9(14):5178-86. PubMed ID: 14613997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture.
    Rovetta G; Maggiani G; Molfetta L; Monteforte P
    Drugs Exp Clin Res; 2001; 27(2):77-81. PubMed ID: 11392057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment.
    Barth J; Jäger D; Mundkowski R; Drewelow B; Welte T; Burkhardt O
    J Antimicrob Chemother; 2008 Sep; 62(3):575-8. PubMed ID: 18515790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.
    McCloskey EV; Yates AJ; Beneton MN; Galloway J; Harris S; Kanis JA
    Bone; 1987; 8 Suppl 1():S35-41. PubMed ID: 2825741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
    Kearns CM; Blakley RL; Santana VM; Crom WR
    Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short courses of intravenous clodronate in the treatment of Paget's disease of bone: a long-term follow-up trial.
    Broggini M; Baratelli E; Cappelli A; Marconi A; Ghiringhelli D; Salzillo A
    Int J Clin Pharmacol Res; 1993; 13(6):301-4. PubMed ID: 8088930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of clodronate after single intravenous, intramuscular and subcutaneous injections in rats.
    Laurén L; Osterman T; Karhi T
    Pharmacol Toxicol; 1991 Nov; 69(5):365-8. PubMed ID: 1839447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.
    Kylmälä T; Tammela TL; Lindholm TS; Seppänen J
    Ann Chir Gynaecol; 1994; 83(4):316-9. PubMed ID: 7537482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of Paget's disease of bone with second-generation bisphosphonates via intravenous infusion].
    Arboleya L; Sánchez J; Iglesias G; Arranz JL
    Rev Clin Esp; 1993 Dec; 193(9):467-71. PubMed ID: 8108576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer.
    Biesma B; Pokorny R; Kovarik JM; Duffy FA; Willemse PH; Mulder NH; de Vries EG
    Cancer Res; 1993 Dec; 53(24):5915-9. PubMed ID: 8261403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.